Related Experiment Video
Updated: Aug 5, 2026
08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Anti-thrombotic therapy after mitral valve surgery
Bilal H Kirmani1,2, A Marc Gillinov3, Luke J Rogers4,5
1Cardiac Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.
Summary
Current guidelines for antithrombotic medication after mitral valve interventions often rely on data from aortic valve procedures. This review highlights the higher thrombotic risk in mitral valve disease and explores current uncertainties.
Area of Science:
- Cardiology
- Thrombosis Research
- Medical Guidelines
Background:
- European and American guidelines provide recommendations for antithrombotic management post-mitral valve interventions.
- Evidence supporting these guidelines is often derived from aortic valve procedure studies.
- Mitral valve disease and interventions carry a substantially higher thrombotic risk compared to aortic procedures.
Purpose of the Study:
- To examine the pathophysiological basis of thrombosis in mitral valve conditions.
- To review current guideline recommendations and supporting evidence for antithrombotic therapy.
- To identify and discuss existing uncertainties in the management of these patients.
Main Methods:
- Literature review of European and American guidelines.
- Analysis of pathophysiological mechanisms of thrombosis in mitral valve disease.
- Evaluation of evidence supporting current recommendations.
Main Results:
- Thrombotic risk is significantly elevated in mitral valve disease compared to aortic valve disease.
- Guideline recommendations may not fully account for the heightened thrombotic risk in mitral valve interventions.
- Significant uncertainties remain regarding optimal antithrombotic strategies.
Conclusions:
- There is a critical need to re-evaluate antithrombotic strategies for mitral valve interventions.
- Further research is required to address the specific thrombotic risks associated with mitral valve disease.
- Guidelines should be updated to reflect the higher thrombotic risk and current evidence.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...